Swiss Re's Term and Health Watch 2012 reports significant increases in UK Life Assurance Protection Gap, overall UK long-term protection market remains resilient in 2011

11 June 2012, London

- UK Life Assurance Protection Gap increases to GBP 2.4 trillion in 2011 - Term and Health Watch 2012 finds overall industry resilience and optimism despite economic headwinds - Increase in UK critical illness (+3.1%) and new whole policies (+7.9%) but falls in sales of new term assurance (-3.4%) and income protection policies (-0.2%) - Report highlights need for greater clarity in communication to build consumer trust as a key issue in the coming year

Swiss Re today releases its annual snapshot of the level of new individual protection business, Term & Health Watch 2012. The report finds an overall stable view of the long-term protection market with insurers and intermediaries optimistic of future growth despite the economic headwinds of the last year. Increases in new critical illness sales and whole life business offset a decline in new term assurance sales and income protection policies. The report describes an increase in the UK Life Assurance and Income Protection Gaps over the past ten years and calls for greater clarity in messaging from the government to consumers regarding how welfare reforms will impact their personal circumstances.

Increasing Protection Gap
Swiss Re's Term and Health Watch 2012 has found that the Life Assurance Protection Gap for the UK has increased by 20% from £2.0 trillion to £2.4 trillion over the past ten years. On average, this gap amounts to around £100,000 per person, with the amount of under-insurance greatest among single parents, couples with children and those aged 35 and under.

Swiss Re's UK CEO, Russell Higginbotham, says: "Under-insurance in both the life insurance and income protection areas is proving to be a long-term problem in the UK. The industry is faced with the challenge of better communicating to consumers how to alleviate the financial burden placed on families and dependents in difficult times. Simple life assurance cover is not expensive; for example, a healthy 35-year-old male non-smoker would only pay around £2 per week for £100,000 of life cover to age 65. "

The Income Protection Gap has increased by 46% over the past decade from £130 billion annual benefit to £190 billion annual benefit between 2002 and 2012.

Industry Resilience
Term and Health Watch finds a mixed picture in the overall UK long-term protection market. New term assurance sales decreased a reported 3.4% with 1,488,106 policies in 2011. Income protection sales fell 0.2% to 110,472 policies. On the positive side, new whole life business increased by 7.9%, totalling 400,682 policies in 2011, while critical illness sales increased by 3.1% to 551,382 policies.

Although falls in uptake were observed in two product areas, Term and Health Watch 2012 shows that the industry is generally resilient in the face of difficult economic conditions in the UK. However, there is still a burden of responsibility on the industry to maintain high standards to satisfy both consumer and regulatory expectation. 

Russell Higginbotham says: "The protection market has coped pretty well with the difficulties presented by the economy. The tougher conditions and changes coming in the market mean we will have to adopt the highest possible standards to satisfy more demanding customers and a regulator prepared to intervene at an earlier stage. I feel very confident in our ability to do this."

Optimism in critical illness cover
The growth in critical illness cover at the consumer level echoes the positive development for critical illness cover arranged through the workplace reported in April in Group Watch 2012. This can be seen as a further sign of growing confidence among consumers, especially in regards to claims management.

Ron Wheatcroft, co-author of Term and Health Watch 2012, says: "We believe that the growth in critical illness policies reflects some of the more positive messages about claims payment rates which have been communicated. These messages are, in turn, improving both consumer and intermediary confidence in the product."

Survey reveals optimistic outlook
Term and Health Watch 2012 also includes the findings of an opinion survey conducted among 45 leading product providers, intermediaries and opinion formers.

The survey results reveal optimism regarding growth in the protection market for the rest of 2012 and beyond. There are challenges presented by regulatory and legislative changes such as the Retail Distribution Review (RDR). The overall expectation, however, is that the changes in general will stimulate interest in protection and that this will be beneficial to the consumer.

Ron Wheatcroft says: "The interest is really at industry level as protection will help cash flow as advisers transition to an RDR world where commission on investment sales is banned. We also expect the outcome of the Mortgage Market Review to place a greater emphasis on the use of financial products to protect and repay mortgage loans."

Term and Health Watch 2012 also finds that the move to gender-neutral pricing is acting as a stimulus for the industry to think about the opportunities this presents. There is an expectation that momentum will grow as the 21 December deadline for the implementation of the directive approaches.

Need for greater clarity
Moving forward, the report cites a need for greater clarity in messaging from government to consumers if we are to move from a broad awareness of the welfare reform changes taking place to doing something about their own circumstances.

Higginbotham says: "We are about to see a period of unprecedented change which includes a greater need for self-responsibility. Whatever distribution market and models emerge, insurers, employers and regulators need clear and unequivocal statements showing how consumers can move beyond a greater awareness of the direction of change to getting something done." 

Term and Health Watch Findings Summary:

Product Type

 2011

 2010

% change

Term assurance

1,488,106

1,540,798

-3.4%

Critical illness

551,382

534,561

+3.1%

Whole life

400,682

371,467

+7.9%

Income protection

110,472

110,743

-0.2%

The figures in this table represent the sum of the findings from Swiss Re's survey of the UK individual protection business.

 

Notes to Editors

For more information on Term and Health Watch 2012 and/or access to experts and managers related to this release please contact Swiss Re media relations: media_relations@swissre.com or +41(0)43 285 7171.

Term and Health Watch 2012 analyses new individual long-term protection sales in the UK market in 2011. It also considers the prospects for the protection market for 2012 and beyond, taking into account the views of 45 individuals from product providers, intermediaries and industry commentators. Term and Health Watch 2012  is the partner publication of Swiss Re's review of the group risk market, Group Watch 2012, which was published in April 2012.

Swiss Re
The Swiss Re Group is a leading wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. Dealing direct and working through brokers, its global client base consists of insurance companies, mid-to-large-sized corporations and public sector clients. From standard products to tailor-made coverage across all lines of business, Swiss Re deploys its capital strength, expertise and innovation power to enable the risk taking upon which enterprise and progress in society depend. Founded in Zurich, Switzerland, in 1863, Swiss Re serves clients through a network of over 60 offices globally and is rated "AA-" by Standard & Poor's, "A1" by Moody's and "A+" by A.M. Best. Registered shares in the Swiss Re Group holding company, Swiss Re Ltd, are listed on the SIX Swiss Exchange and trade under the symbol SREN. For more information about Swiss Re Group, please visit: www.swissre.com and follow us on Twitter @swissre.

Cautionary note on forward-looking statements
Certain statements and illustrations contained herein are forward-looking. These statements and illustrations provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical fact or current fact. Forward-looking statements typically are identified by words or phrases such as “anticipate“, “assume“, “believe“, “continue“, “estimate“, “expect“, “foresee“, “intend“, “may increase“ and “may fluctuate“ and similar expressions or by future or conditional verbs such as “will“, “should“, “would“ and “could“. These forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Swiss Re’s actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed or implied by such statements. Such factors include, among others:

  • further instability affecting the global financial system and developments related thereto, including as a result of concerns over, or adverse developments relating to, sovereign debt of Eurozone countries;
  • further deterioration in global economic conditions;
  • Swiss Re’s ability to maintain sufficient liquidity and access to capital markets, including sufficient liquidity to cover potential recapture of reinsurance agreements, early calls of debt or debt-like arrangements and collateral calls under derivative contracts due to actual or perceived deterioration of Swiss Re’s financial strength;
  • the effect of market conditions, including the global equity and credit markets, and the level and volatility of equity prices, interest rates, credit spreads, currency values and other market indices, on Swiss Re’s investment assets;
  • changes in Swiss Re’s investment result as a result of changes in its investment policy or the changed composition of its investment assets, and the impact of the timing of any such changes relative to changes in market conditions;
  • uncertainties in valuing credit default swaps and other credit-related instruments;
  • possible inability to realise amounts on sales of securities on Swiss Re’s balance sheet equivalent to their mark-to-market values recorded for accounting purposes;
  • the outcome of tax audits, the ability to realise tax loss carry forwards and the ability to realise deferred tax assets (including by reason of the mix of earnings in a jurisdiction or deemed change of control), which could negatively impact future earnings;
  • the possibility that Swiss Re’s hedging arrangements may not be effective;
  • the lowering or loss of financial strength or other ratings of Swiss Re companies, and developments adversely affecting Swiss Re’s ability to achieve improved ratings;
  • the cyclicality of the reinsurance industry;
  • uncertainties in estimating reserves;
  • uncertainties in estimating future claims for purposes of financial reporting, particularly with respect to large natural catastrophes, as significant uncertainties may be involved in estimating losses from such events and preliminary estimates may be subject to change as new information becomes available;
  • the frequency, severity and development of insured claim events;
  • acts of terrorism and acts of war;
  • mortality, morbidity and longevity experience;
  • policy renewal and lapse rates;
  • extraordinary events affecting Swiss Re’s clients and other counterparties, such as bankruptcies, liquidations and other credit-related events;
  • current, pending and future legislation and regulation affecting Swiss Re or its ceding companies;
  • legal actions or regulatory investigations or actions, including in respect of industry requirements or business conduct rules of general applicability;
  • changes in accounting standards;
  • significant investments, acquisitions or dispositions, and any delays, unexpected costs or other issues experienced in connection with any such transactions;
  • changing levels of competition; and
  • operational factors, including the efficacy of risk management and other internal procedures in managing the foregoing risks.

These factors are not exhaustive. Swiss Re operates in a continually changing environment and new risks emerge continually. Readers are cautioned not to place undue reliance on forward-looking statements. Swiss Re undertakes no obligation to publicly revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.

This communication is not intended to be a recommendation to buy, sell or hold securities and does not constitute an offer for the sale of, or the solicitation of an offer to buy, securities in any jurisdiction, including the United States and the United Kingdom. Any such offer will only be made by means of a prospectus or offering memorandum, and in compliance with applicable securities laws.